Literature DB >> 1711208

Characterization of the decay-accelerating factor gene promoter region.

U K Ewulonu1, L Ravi, M E Medof.   

Abstract

Decay-accelerating factor (DAF) expression modulates susceptibility of cells to autologous complement attack. To characterize the regulatory region controlling DAF gene transcription, genomic DNA extending from 815 base pairs (bp) upstream to approximately 4 kilobases downstream of DAF's AUG codon (designated +1) was cloned and sequenced. The 5' flanking sequence showed 59-76% G + C content (-355 to +1), at least one GC box(es) (-135 to -131), and variable length sequences (from -629 to -285) conforming to the motifs TCCTCC and TCn. Nuclease S1 digestions and primer extensions localized a major transcriptional start site to -82/-81, 38 bp downstream of a possible TATA variant, (A)TTTAA. In COS cell transfections, the sequence encompassing -815 to -67 functioned 2.5% as efficiently as the Rous sarcoma virus 3' long terminal repeat, but following deletion upstream of -355 its activity increased approximately 4-fold. Two octanucleotides exhibiting partial homology to phorbol 12-myristate 13-acetate (PMA) and cAMP responsive elements (PREs and CREs, respectively) were detected, and the respective modulators enhanced transcriptional efficiency 2- and approximately 10-fold, respectively. Thus, the DAF gene promoter (i) exhibits sequences resembling both conventional and unconventional transcriptional control elements, (ii) possesses a region with negative regulatory activity, and (iii) responds to PMA and cAMP induction presumably via PRE- and CRE-like enhancer elements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711208      PMCID: PMC51728          DOI: 10.1073/pnas.88.11.4675

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The regulators of complement activation (RCA) gene cluster.

Authors:  D Hourcade; V M Holers; J P Atkinson
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes.

Authors:  J L Klein; T B Shows; B Dupont; J A Trapani
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

3.  Transcriptional "silencer" element in rat repetitive sequences associated with the rat insulin 1 gene locus.

Authors:  L Laimins; M Holmgren-König; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Repression mediates cell-type-specific expression of the rat growth hormone gene.

Authors:  P R Larsen; J W Harney; D D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Nucleotide sequence analysis of the chloramphenicol resistance transposon Tn9.

Authors:  N K Alton; D Vapnek
Journal:  Nature       Date:  1979 Dec 20-27       Impact factor: 49.962

6.  Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites.

Authors:  A C Johnson; S Ishii; Y Jinno; I Pastan; G T Merlino
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

7.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid.

Authors:  M E Medof; E I Walter; W L Roberts; R Haas; T L Rosenberry
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

10.  Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.

Authors:  L M Matrisian; P Leroy; C Ruhlmann; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

View more
  14 in total

1.  Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Michael S Diamond; John P Atkinson; Ranjit Ray
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Identification and characterization of new human medium reiteration frequency repeats.

Authors:  J Jurka; D J Kaplan; C H Duncan; J Walichiewicz; A Milosavljevic; G Murali; J F Solus
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

3.  Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure.

Authors:  Gitanjali A Narayanan; Iain A Murray; Gowdahalli Krishnegowda; Shantu Amin; Gary H Perdew
Journal:  J Pharmacol Exp Ther       Date:  2012-05-02       Impact factor: 4.030

4.  Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

Authors:  David M Cauvi; Gabrielle Cauvi; K Michael Pollard
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

5.  Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor.

Authors:  Daniel P O'Brien; Judith Romero-Gallo; Barbara G Schneider; Rupesh Chaturvedi; Alberto Delgado; Elizabeth J Harris; Uma Krishna; Seth R Ogden; Dawn A Israel; Keith T Wilson; Richard M Peek
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

6.  Prostaglandin E2 and Krüppel-like transcription factors synergistically induce the expression of decay-accelerating factor in intestinal epithelial cells.

Authors:  Jinyi Shao; Vincent W Yang; Hongmiao Sheng
Journal:  Immunology       Date:  2008-04-16       Impact factor: 7.397

7.  PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor.

Authors:  Manu Banadakoppa; Pawel Goluszko; Daniel Liebenthal; Bogdan J Nowicki; Stella Nowicki; Chandra Yallampalli
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-05

Review 8.  Host genetic determinants of influenza pathogenicity.

Authors:  Tsai-Yu Lin; Abraham L Brass
Journal:  Curr Opin Virol       Date:  2013-08-08       Impact factor: 7.090

9.  Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.

Authors:  Manu Banadakoppa; Daniel Liebenthal; David E Nowak; Petri Urvil; Uma Yallampalli; Gerald M Wilson; Aparna Kishor; Chandra Yallampalli
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

10.  A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.

Authors:  J M Heckmann; H Uwimpuhwe; R Ballo; M Kaur; V B Bajic; S Prince
Journal:  Genes Immun       Date:  2009-08-13       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.